Zhejiang Gongdong Medical Technology Co Ltd (605369) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Gongdong Medical Technology Co Ltd (605369) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥59.82 Million ≈ $8.75 Million USD) by net assets (CN¥1.73 Billion ≈ $253.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Gongdong Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 605369 net assets for net asset value and shareholders' equity analysis.
Zhejiang Gongdong Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Gongdong Medical Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
0.105x |
|
Guangzhou Pearl River Industrial Development Co Ltd
SHG:600684
|
-0.001x |
|
Spearhead Integrated Marketing
SHE:300071
|
-0.019x |
|
China Steel Chemical Corp
TW:1723
|
0.022x |
|
Liberty Gold Corp
TO:LGD
|
-0.229x |
|
Beijing Bohui Innovation Technology Co Ltd
SHE:300318
|
-0.027x |
|
Nilfisk Holding A/S
CO:NLFSK
|
0.061x |
|
Hinova Pharmaceuticals Inc. A
SHG:688302
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhejiang Gongdong Medical Technology Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Gongdong Medical Technology Co (605369) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.71 Billion ≈ $249.68 Million |
CN¥253.96 Million ≈ $37.16 Million |
0.149x | +21.51% |
| 2024-12-31 | CN¥1.72 Billion ≈ $251.33 Million |
CN¥210.38 Million ≈ $30.79 Million |
0.122x | +8.26% |
| 2023-12-31 | CN¥1.64 Billion ≈ $239.77 Million |
CN¥185.39 Million ≈ $27.13 Million |
0.113x | -36.29% |
| 2022-12-31 | CN¥1.59 Billion ≈ $232.99 Million |
CN¥282.75 Million ≈ $41.38 Million |
0.178x | -33.91% |
| 2021-12-31 | CN¥1.39 Billion ≈ $203.11 Million |
CN¥372.99 Million ≈ $54.58 Million |
0.269x | +34.03% |
| 2020-12-31 | CN¥1.21 Billion ≈ $176.76 Million |
CN¥242.18 Million ≈ $35.44 Million |
0.200x | -33.58% |
| 2019-12-31 | CN¥405.25 Million ≈ $59.30 Million |
CN¥122.33 Million ≈ $17.90 Million |
0.302x | +0.63% |
| 2018-12-31 | CN¥341.42 Million ≈ $49.96 Million |
CN¥102.42 Million ≈ $14.99 Million |
0.300x | -11.44% |
| 2017-12-31 | CN¥252.52 Million ≈ $36.95 Million |
CN¥85.54 Million ≈ $12.52 Million |
0.339x | -26.02% |
| 2016-12-31 | CN¥188.07 Million ≈ $27.52 Million |
CN¥86.12 Million ≈ $12.60 Million |
0.458x | -- |
About Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more